METRAZOL AS A DIAGNOSTIC AID IN EPILEPSY
Abstract
Differences of convulsive reactivity are manifested when a stimulating agent to the central nervous system is given to a group of individuals.
In 84 patients suffering from functional psychoses and with a standard dose of metrazol used as a stimulant, 1.19% developed a seizure. The one patient having a convulsion was quite possibly incorrectly diagnosed. Of 34 epileptic patients, 47.05 per cent developed seizures on a dose equal to that for schizophrenic and other patients.
Patients developing grand mal seizures with a dose of five cubic centimeters or less per 100-pound body weight (45. 5 kilograms) have an increased irritability of the nervous system and epilepsy is to be suspected in the absence of any evidence of organic disease of the brain.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
